Immunome Inc. (IMNM) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.43 | +51.4% |
| 2024 | $-5.00 | +7.1% |
| 2023 | $-5.38 | -74.1% |
| 2022 | $-3.09 | -44.4% |
| 2021 | $-2.14 | +59.3% |
| 2020 | $-5.26 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.43 | +51.4% |
| 2024 | $-5.00 | +7.1% |
| 2023 | $-5.38 | -74.1% |
| 2022 | $-3.09 | -44.4% |
| 2021 | $-2.14 | +59.3% |
| 2020 | $-5.26 | — |